Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Industry Awards.
Sort by 
Winners announced at the 2026 Women in Pharma Awards
The 2026 Women in Pharma Awards gala took place on 29 April at the Crowne Plaza Hotel, Santry, honouring outstanding women across Ireland's pharma and life sciences sector. Emma Kilgallon of West Pharmaceutical Services received the Overall Leader Award as the evening's top honour, with winners named across more than fifteen categories.
PCI Pharma Services commits over $1 billion to expand sterile fill-finish and drug-device capabilities
US-based global CDMO PCI Pharma Services has announced a series of major infrastructure investments exceeding $1 billion across its US and European operations, substantially expanding its sterile fill-finish and drug-device combination delivery capabilities.
Aptus Pharma doubles revenue and expands portfolio to 250 formulations in growth push
India-based BSE SME-listed Aptus Pharma Limited has doubled its revenue and expanded its product portfolio to over 250 formulations, as the pharmaceutical company accelerates multi-vertical expansion toward pan-India presence by 2030.
Helus Pharma adds Dr. Robert Langer and Dr. Stephen Brannan to Scientific Advisory Board
Clinical-stage pharmaceutical company Helus Pharma has appointed renowned biotechnology pioneer Dr. Robert Langer and CNS drug development expert Dr. Stephen Brannan to its Scientific Advisory Board to advance its mental health pipeline.
Amneal Pharmaceuticals enters US commercial market with first inhalation products from Tipperary
Tipperary-based Amneal Pharmaceuticals has launched its first two metered-dose inhalation products on the US commercial market, marking a significant milestone for the Cashel facility and the wider Tipperary regional economy.
Helus Pharma partners with TARA Mind to support veteran recruitment for HLP003 trial
Helus Pharma has partnered with TARA Mind and Veterans Exploring Treatment Solutions to support veteran recruitment for the clinical-stage pharmaceutical company’s Phase 3 PARADIGM HLP003 programme for major depressive disorder.
Record Exports, Record Ambition: How GLP-1 Medicines Reshaped Ireland’s Pharmaceutical Landscape
Ireland’s pharmaceutical exports hit a record €139 billion in 2025, driven by surging GLP-1 medicine component production. The Goodbody Economic Report for IPHA sets an agenda for sustaining Ireland’s position as the EU’s second-largest pharmaceutical exporter.
Escaping Proof-of-Concept Purgatory: Ireland’s Biopharma Sector Confronts Its Generative AI Challenge
BioPharmaChem Ireland’s Generative AI for Life Sciences Playbook 2025 identifies proof-of-concept purgatory as the defining obstacle to AI adoption across Ireland’s biopharma sector. Over 100 validated use cases map a practical path from experimentation to production-scale value.
ABM Ireland named Gold Sponsor of Life Sciences Industry Awards 2026
ABM Ireland has been announced as Gold Sponsor of the Life Sciences Industry Awards 2026, bringing integrated facility and engineering services expertise to the programme ahead of the awards gala on 28 May at the Crowne Plaza Hotel, Santry. The partnership reflects ABM Ireland's alignment with organisations demonstrating excellence in innovation, operational standards, and sector leadership across Ireland's life sciences industry.
Crystal Pharmatech deploys first dedicated MicroED platform in Asia-Pacific region
China-based pharmaceutical CRO/CDMO Crystal Pharmatech has become the first company in the Asia-Pacific region to deploy a dedicated MicroED platform, advancing industrial-grade solid-state characterisation capabilities for global drug development clients.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
